PCR Biosystems today announced the launch of its new Lyo-Ready Inhibitor-Tolerant reagents, bringing the company’s powerful inhibitor-tolerant chemistry into its growing range of lyophilisation-ready reagents for molecular diagnostics. This new product line enables developers to build highly stable, ambient-temperature assays without compromising performance in challenging sample types such as blood, saliva, and other inhibitor-rich matrices.
“Achieving consistent results from complex biological samples remains a major challenge for assay developers,” said Alex Wilson, Co-Founder at PCR Biosystems. “Our new Lyo-Ready Inhibitor-Tolerant reagents bring together inhibitor tolerance and lyo-ready stability to deliver high-sensitivity qPCR and RT-qPCR across a wide range of challenging workflows, without compromising performance.”
Read More
